Article Versions Notes

Masson-Lecomte A, Vaillant V, Roumiguié M, Lévy S, Pradère B, Peyromaure M, Duquesne I, De La Taille A, Lebâcle C, Panis A, et al. Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee. Cancers. 2022; 14(21):5452. https://doi.org/10.3390/cancers14215452

Masson-Lecomte, Alexandra, Victoire Vaillant, Mathieu Roumiguié, Stéphan Lévy, Benjamin Pradère, Michaël Peyromaure, Igor Duquesne, Alexandre De La Taille, Cédric Lebâcle, Adrien Panis, and et al. 2022. "Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee" Cancers 14, no. 21: 5452. https://doi.org/10.3390/cancers14215452

Masson-Lecomte, A., Vaillant, V., Roumiguié, M., Lévy, S., Pradère, B., Peyromaure, M., Duquesne, I., De La Taille, A., Lebâcle, C., Panis, A., Traxer, O., Leon, P., Hulin, M., Xylinas, E., Audenet, F., Seisen, T., Loriot, Y., Allory, Y., Rouprêt, M., & Neuzillet, Y., on behalf of the French CCAFU Bladder Cancer Group. (2022). Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee. Cancers, 14(21), 5452. https://doi.org/10.3390/cancers14215452